Welcome to the Renal-Electrolyte and Hypertension Division at the University of Pennsylvania, where a legacy of excellence in patient care, research, and education drives our relentless pursuit of innovation and discovery in advancing kidney health. It is a privilege to lead this extraordinary division as we push the boundaries of nephrology and transform care for patients locally, nationally, and globally.
At Penn Kidney, we are redefining what is possible in clinical nephrology through exceptional and specialized programs that address the full spectrum of kidney diseases. Our comprehensive programs in glomerular disease, onconephrology, kidney stones, polycystic kidney disease, complex hypertension, and home dialysis integrate the latest scientific advances to optimize patient outcomes. As the oldest and largest kidney and pancreas transplant program in the region, Penn’s Transplant Program achieves some of the best outcomes nationwide, standing at the forefront of transplantation science. With a focus on patient-centered care, we continue to expand access to cutting-edge therapies while ensuring that every patient benefits from precision medicine and individualized treatment strategies.
Our research enterprise is equally ambitious, spanning basic, translational, and clinical science. We are pioneering breakthroughs in genomics and epigenomics to uncover the molecular drivers of kidney disease, leading the way in uncovering the pathogenesis of immunologic kidney disorders, and developing novel therapeutic strategies through bioengineering and precision nephrology. Our U2C/TL1-funded research training program equips the next generation of investigators with the tools needed to advance discovery and accelerate clinical translation, ensuring Penn’s leadership in kidney research for years to come.
Our commitment to underserved communities remains a cornerstone of our mission. Through dedicated screening and engagement programs, we are addressing disparities in kidney disease outcomes, improving access to care, and strengthening partnerships with local and national organizations to create lasting impact. Our faculty, trainees, staff, and students are deeply engaged in initiatives that bring innovative kidney care solutions to underserved populations, reinforcing Penn’s role as a catalyst for change in nephrology and public health.
Education and mentorship are the foundation of our division. Our exceptional Nephrology Fellowship Program, one of the largest in the country, continues to attract outstanding trainees, and offers unparalleled clinical and research opportunities that prepare the next generation of nephrologists for leadership roles. With an emphasis on faculty development, interdisciplinary collaboration, and translational science, we foster an environment where curiosity, creativity, and innovation thrive.
At Penn Kidney, we are not just treating kidney disease—we are transforming the future of kidney medicine through bold innovation, groundbreaking research, and compassionate care. Whether you are a patient, researcher, trainee, or colleague, I invite you to join us in shaping the next era of nephrology.
Kirk Campbell, MD
Professor of Medicine and Chief, Renal-Electrolyte and Hypertension Division